Colli-Pee UAS + Revolution
Colli-Pee UAS Combined with nRichDX Revolution System, a Promising Urinary Cell-free DNA Collection, Preservation and Extraction Workflow.
View PosterConnect first-void urine collection and preservation with recovery-focused molecular sample preparation.
Preanalytical decisions influence the biological material presented to downstream molecular workflows. For urine liquid biopsy, that process begins with how the specimen is collected, preserved, transported, and prepared before extraction.
nRichDX and Novosanis, an OraSure Technologies company, have collaborated on a urine liquid biopsy workflow connecting first-void urine collection and preservation using Colli-Pee UAS™ with molecular sample preparation using the nRichDX Revolution platform.
The combined approach has been evaluated for controlled first-void urine collection, preservative compatibility, and downstream extraction of circulating nucleic acids from urine samples.
Volumetric first-void urine collection helps standardize the specimen entering the workflow.
UAS preservative is designed to stabilize molecular material in collected first-void urine.
Revolution sample preparation supports extraction of circulating nucleic acids from urine.
Standardized first-void urine collection, preservation, and downstream molecular extraction can be considered as one connected upstream workflow rather than independent steps.
Colli-Pee™ is designed for volumetric collection of first-void urine.
Colli-Pee UAS™ configurations support non-invasive self-collection of a defined first-void urine volume together with preservative designed for molecular sample stabilization.
Paired with Revolution sample preparation, the workflow connects collection and preservation upstream with recovery-focused molecular extraction in the laboratory.
The joint Novosanis/DNA Genotek and nRichDX application note evaluates collection, preservation, and extraction of cell-free DNA from first-void urine using Colli-Pee UAS™ and the Revolution Sample Prep System.
The study evaluated preservative compatibility, urine storage conditions, molecular recovery, and downstream detection as part of a connected preanalytical workflow.
nRichDX and collaborators have evaluated urine liquid biopsy workflows across multiple analytes, sample volumes, collection approaches, and downstream molecular applications.
Colli-Pee UAS Combined with nRichDX Revolution System, a Promising Urinary Cell-free DNA Collection, Preservation and Extraction Workflow.
View PosterFirst-void urine as a non-invasive proxy for plasma in prostate cancer-related liquid biopsy applications.
View PosterEnhanced Extraction and Preservation of Circulating Cell-Free RNA from 50 mL Cell-Free Urine.
View PosterEnhancing urine-based cfDNA detection for prostate cancer diagnosis through increased input volume.
View PosterHear more about the nRichDX and Novosanis collaboration and the combined approach to first-void urine collection, preservation, and molecular sample preparation.
Explore application data, posters, publications, and technical resources spanning first-void urine collection, preservation, high-volume extraction, cfDNA, cfRNA, and downstream analysis.